Tweenvest Stocks

Birzeit Pharmaceuticals Company (PLSE: BPC)

Health Care · Pharmaceuticals · PS

$3.90

-0.76% today · +4.0% 1Y

Birzeit Pharmaceuticals Company (PLSE: BPC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $151.18M.

Over the last twelve months the share price has gained 4.0%, trading between 3.60 and 4.45.

Tweenvest scores Birzeit Pharmaceuticals Company across four factors: quality 79/100, value 53/100, growth 36/100, dividend 33/100. Its strongest factor is quality.

BPC price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$151.18M
Revenue (TTM)
$46.66M
P/E
14.08
EPS
0.28
Dividend yield
1.28%
Beta (5Y)
-0.16
52-week high
$4.45
52-week low
$3.60
Avg volume (3M)
—
Shares outstanding
38.76M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Jagsonpal Pharmaceuticals LimitedNSEI: JAGSNPHARM$153.68MRs225.60-2.65%
Fermenta Biotech LimitedBSE: 506414$153.31MRs517.50-6.14%
Mayne Pharma Group LimitedASX: MYX$152.01MAU$2.66-6.67%
Amrutanjan Health Care LimitedBSE: 590006$151.84MRs508.30-1.07%
Memphis Pharmaceuticals & Chemical IndustriesCASE: MPCI$150.31MEGP346.01-0.14%
BINEX Co., Ltd.KOSDAQ: A053030$150.19M₩6,340.00-1.09%
Panion & Bf Biotech Inc.TWSE: 1760$149.36MNT$55.70+2.01%
TTK Healthcare LimitedBSE: 507747$149.19MRs1,021.85+0.74%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.